highperformr logo

Labcorp Drug Development's Overview

Total employees67000
HeadquartersPrinceton
Founded1996

Labcorp Drug Development, formerly Covance, is a global contract research organization (CRO) and a segment of Labcorp. It provides a wide array of services to the pharmaceutical and biotechnology industries, supporting clients from early-stage research and preclinical studies through all phases of clinical trials (Phase I-IV) and into market access. Key services include central laboratory services, clinical trial management, bioanalytical services, early development research, and regulatory consulting. Labcorp Drug Development aims to accelerate the delivery of innovative medicines to patients by leveraging its scientific expertise, global reach, and advanced technologies.

Where is Labcorp Drug Development's Headquarters?

HQ Function

Serves as a key operational and strategic center for Labcorp's global drug development services, including clinical operations, project management, and scientific leadership.

Notable Features:

The Princeton campus is part of a larger office park environment, typically featuring modern office buildings and potentially specialized laboratory or data management facilities suited for CRO operations.

Work Culture:

Characterized by a focus on scientific rigor, collaboration, innovation, and client service in the fast-paced pharmaceutical development sector. Emphasis on quality, ethics, and patient impact.

HQ Significance:

Represents a significant center for global pharmaceutical research and development services, building on Covance's long history in the CRO industry.

Values Reflected in HQ: The operations at this site reflect a commitment to advancing health, scientific excellence, and providing comprehensive solutions to pharmaceutical partners.

Location:

Labcorp Drug Development supports global clinical trials and drug development programs with a significant presence across North America, Europe, Asia-Pacific, Latin America, and Africa. Functions supported globally include Phase I-IV clinical trial management, central laboratory services, bioanalytical testing, preclinical research, regulatory consulting, market access solutions, and companion diagnostics development. This extensive network allows them to conduct complex, multi-regional studies for pharmaceutical and biotechnology clients worldwide.

Street Address:

210 Carnegie Center Drive

City:

Princeton

State/Province:

New Jersey

Country:

USA

Labcorp Drug Development's Global Presence

Indianapolis, Indiana/USA

Address: 8201 Scicor Drive, Indianapolis, IN 46214, USA (Example of a major site)

Serves as a critical hub for Labcorp's central laboratory services in North America and globally, providing key data for clinical research.

Geneva/Switzerland

Address: Route de la Corniche 4, 1066 Epalinges, Switzerland (Example, specific address may vary)

Facilitates engagement with European pharmaceutical clients, regulatory bodies, and investigator sites; supports pan-European clinical studies.

Singapore/Singapore

Address: 11 Biopolis Way, #06-01/08 Helios, Singapore 138667 (Example of a major site)

Provides critical infrastructure and expertise for conducting clinical research in the growing Asia-Pacific pharmaceutical market, catering to both global and regional clients.

Buying Intent Signals for Labcorp Drug Development

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of Labcorp Drug Development

As of April 2025, Labcorp Drug Development' leadership includes:

Dr. Paul Pasteur - Executive Vice President and President, Labcorp Drug Development
Jonathan Collins - Chief Financial Officer, Labcorp Drug Development (Note: Labcorp corporate CFO is Glenn A. Eisenberg)
Mark Goldberg, MBBCh - Chief Medical Officer, Labcorp Drug Development
Dr. Bill Hanlon - President, Central Laboratories and Chief Scientific Officer, Labcorp Drug Development

Investors of Labcorp Drug Development

Labcorp Drug Development has been backed by several prominent investors over the years, including:

Labcorp Drug Development is a business segment of Labcorp (NYSE: LH), which is a publicly traded company. Therefore, its 'investors' are the shareholders of Labcorp Holdings Inc. Major institutional investors in Labcorp typically include firms like The Vanguard Group, BlackRock, State Street Corporation, etc.

Executive New Hires/Exits in the Last 12 Months

Hire1
Exits0

Labcorp periodically announces executive changes at the corporate level, which may impact its Drug Development segment. Specific news for the Drug Development segment leadership is often part of broader Labcorp announcements. In the last 12-18 months, Labcorp has had several key corporate appointments.

New Appointments:

Rita M. Khan, Rita M. Khan appointed as SVP and Chief Digital Officer for Labcorp, overseeing digital transformation efforts across the enterprise, including technology and data initiatives relevant to Drug Development.

Technology (Tech Stack) used by Labcorp Drug Development

Discover the tools Labcorp Drug Development uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Labcorp Drug Development Email Formats and Examples

Labcorp Drug Development, as part of Labcorp, generally uses standardized email formats common for large corporations. The most prevalent format is firstname.lastname@labcorp.com. Variations might exist but are less common.

firstname.lastname@labcorp.com

Format

john.doe@labcorp.com

Example

90%

Success rate

News and media

Labcorp Press Release / Business WireFebruary 15, 2024

Labcorp Drug Development Segment Shows Strong Growth in Q4 and Full-Year 2023 Results

Labcorp announced its fourth-quarter and full-year 2023 financial results, with the Drug Development segment (formerly Covance) reporting revenues of $3.16 billion for Q4, an increase of 6.0% from $2.98 billion in Q4 2022. Full-year 2023 revenues for Drug Development were $12.18 billion, up 4.7%. The growth was attributed to continued demand in clinical development and central laboratory services....more

Labcorp Press Release / Business WireOctober 26, 2023

Labcorp Appoints Amy Sumrall as Chief Marketing Officer

Labcorp announced the appointment of Amy Sumrall as executive vice president and chief marketing officer. In this role, Sumrall will lead Labcorp’s global marketing strategy and execution, impacting brand perception and go-to-market strategies for all segments, including Drug Development....more

Fierce BiotechJuly 27, 2023

Labcorp sees drug development demand stabilize after choppy start to year

Labcorp's drug development arm saw demand stabilize in the second quarter of 2023 after a more challenging start to the year. Executives noted a pickup in RFPs and awards, particularly in oncology and early-phase research, indicating a healthier outlook for CRO services....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Labcorp Drug Development, are just a search away.